Company intelligence / Profile preview

Institute of New Medical Technologies

Northbrook, Illinois, United States

Ownership: Private
Employees: ~29
Development stage: Other

Overview

Newmedical Technology markets FDA-cleared (510k) wound care, scar management, and skin care devices such as NewGel+, Silagen, UniTable, and Bone Dice. No pharmaceuticals or clinical therapeutic drugs; all products are medical devices with commercial status. Company has won multiple export awards, holds ISO and cGMP certifications, and delivers globally.

Therapeutic areas: DermatologyOther
Modalities: DeviceBiologic
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Institute of New Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Institute of New Medical Technologies.

Explore the full profile